Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33Prostatic Neoplasms 8Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2Neoplasms 2Mouth Neoplasms 2Lymphedema 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia 2Infertility 2Hodgkin Disease 2Fibrosis 2Carcinoma, Medullary 2Carcinoma, Intraductal, Noninfiltrating 2Anatomic Stage III Breast Cancer AJCC v8 2Anatomic Stage I Breast Cancer AJCC v8 2Uterine Hemorrhage 1Unspecified Adult Solid Tumor, Protocol Specific 1Thyroid Nodule 1Thyroid Cancer, Papillary 1Stomatitis 1Somatostatinoma 1Soft Tissue Neoplasms 1

Interventions

Radiotherapy 4Carboplatin 4Trastuzumab 3Fulvestrant 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Paclitaxel 2Magnetic Resonance Spectroscopy 2Letrozole 2Docetaxel 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1gallium 68 PSMA-11 1fluciclovine F-18 1entrectinib 1Zolpidem 1Vorinostat 1Vinorelbine 1Venlafaxine Hydrochloride 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Lobular × High-Energy Shock Waves × Clear all
NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Vanderbilt-Ingram Cancer Center

Phase 2 Recruiting
30 enrolled

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡